08.04.2020: Nanion Newsbites - March 2020 Recap
Nanion Newsbites: March 2020 Highlights
In the latest edition of our quarterly recap we present a cross-industry study that was performed to collect hERG data on 28 drugs with known torsadogenic risk using a standardized experimental protocol.
Acess the CiPA publication here: A systematic strategy for estimating hERG block potency and its implications in a new cardiac safety paradigm
Additionally, we announced our next webinar: "Validation and optimization of automated patch clamp voltage-gated Ca2+ channel assays"
Date: 28. April 2020
Time: 4:00 PM CET / 10:00 AM EDT
Dr. Marc Rogers (Chief Scientific Officer at Metrion Biosciences) and Dr. András Horváth (Application Scientists at Nanion Technologies) will lead a conversation discussing voltage-gated Ca2+ channel assays and a case example of a drug discovery collaboration that spanned 8 years.
Register for the webinar (Join the conversation Live or Sign up to receive an On-Demand copy)
Lastly, we caught up with Jason Villagomez (Marketing Manager) for a Q&A. Read the full Employee Interview here.
Register for our newsletter here
(please note that you can unsubscribe or edit your email preferences at anytime)